Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency

Maura Faraci, Edoardo Lanino, Concetta Micalizzi, Giuseppe Morreale, Daniela Di Martino, Laura Banov, Patrizia Comoli, Franco Locatelli, Annarosa Soresina, Alessandro Plebani

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Cernunnos-XLF deficiency is a rare CI characterized by a defective DNA DSB repair mechanism. Its clinical manifestations are growth retardation, dysmorphic features, malformations, and severe B- and T-cell lymphopenia. BM failure may complicate the clinical picture. To date, there have been no described patients with CSy undergoing allogeneic HSCT. We report a case of CSy treated successfully with unrelated allogeneic HSCT after a reduced-intensity conditioning regimen. Two yr after HSCT, the patient maintains full donor engraftment, normal hematopoiesis, and progressively improving immune competence, thus suggesting that HSCT may be the treatment of choice for CSy.
Lingua originaleEnglish
pagine (da-a)785-789
Numero di pagine8
RivistaPediatric Transplantation
Volume13
DOI
Stato di pubblicazionePubblicato - 2009

Keywords

  • Cernunnos syndrome
  • congenital immunodeficiency
  • Epstein-Barr virus-post-transplantation lymphoproliferative disease
  • hematopoietic stem cell transplantation

Fingerprint

Entra nei temi di ricerca di 'Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency'. Insieme formano una fingerprint unica.

Cita questo